Shanghai Fosun Chairman Budgets Half Of IPO Millions For Acquisitions
This article was originally published in PharmAsia News
Executive Summary
Shanghai Fosun Pharmaceutical Chairman Chen Qiyu believes his company, already China's largest drug maker, is now poised to compete on the international market thanks to its recent initial public offering in Hong Kong.